could glp-1 be the next mental health drug Impact of Receptor Agonists (GLP-1 RAs) on Health: A Systematic Review | Current Treatment Options in Psychiatry GLP-1 Receptor Agonists in Mood

Compared with LIXI, LIR is more effective in improving blood glucose and reducing weight, and both treatments are well tolerated (75, 77, 78)

Encyclopedia of Signaling Molecules

However, it is worth noting that most preclinical studies do not incorporate a dose titration phase, a gradual increase to the therapeutic maintenance dose, which is standard in clinical settings

Glucagon-like peptide 1 (GLP-1) is an incretin 30 amino-acid peptide hormone produced in hindbrain neurons and in specialized enteroendocrine cells (L cells) in the distal small and large intestines that is released after food intake [23, 24]

69% of patients achieved more than 10% weight loss compared to 9% on placebo